The advances in the approach of type 2 diabetes involves simplifying the treatments and facilitating the adaptation of patients, according to the more than 300 endocrinology specialists who have participated in the meeting 'Click: A click from simplifying diabetes', organized by Lilly.
Patients with diabetes have to introduce changes in their lifestyle that condition their day to day.In addition to food and exercise guidelines, they must adjust meal schedules, adapt their work or daily activity and, on some occasions, use injectable treatments that require strict dose adjustments, and sometimes complex, based on automation of theglycemia
However, in recent years new therapeutic alternatives have emerged to facilitate the adaptation of patients to an injectable treatment and improve their feeling of independence.
In this sense, Dr. Ignacio Conget, of the Clinic Hospital in Barcelona, stressed that the recent launch of Doraglutida in Spain, a new weekly anti -dialGreat efficiency and security, and a weekly administration that brings great freedom to patients. "
In addition, attendees have stressed that with the incorporation of new therapeutic families, diabetes treatment is becoming more complex, so health professionals demand to have messages and concepts of simplicity that help improve medical-patient conversation.
"The complexity of many of the antidiabetic treatments is a very important stumbling block that often makes the patient himself reject an injectable therapy in advance," said Santiago Tofé, from the Son Espases hospital in Palma de Mallorca.
Faced with this, the Weekly Administration of Dreamaglutida is accompanied by a designed pen "for greater comfort of the patient" that also allows "during use does not have to do or manipulate the needle."
